Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Vamsi Kota"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The introduction of tyrosine kinase inhibitors (TKIs) has transformed the treatment of chronic myeloid leukemia (CML). Each approved TKI has its own risk-benefit profile, and patients have choices across lines of therapy. Identifying the initial and
Externí odkaz:
https://doaj.org/article/b99b38b0ef804e3c9d392b6116b445f5
Autor:
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M. Zeidan, Vamsi Kota, Mark R. Litzow
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/768054ee7a0b494192b71e0f348ee872
Autor:
Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Emily C. Craver, Zhuo Li, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam Duvall, Madelyn Burkart, Danielle Bradshaw, Yasmin Abaza, Maximilian Stahl, Neil Palmisiano, Guru Subramanian Guru Murthy, Amer M. Zeidan, Vamsi Kota, Mrinal M. Patnaik, Mark R. Litzow
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
While there is clear evidence to suggest poorer outcome associated with multi-hit (MH) TP53 mutation compared to single-hit (SH) in lower-risk myelodysplastic syndrome (MDS), data are conflicting in both higher-risk MDS and acute myeloid leukemia (AM
Externí odkaz:
https://doaj.org/article/c1694d4dbade4d11b7fd3ea5b5113ad5
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/c3363f8980354162b060c61cfdff423d
Autor:
Talha Badar, Ehab Atallah, Ravi Narra, Alice Mims, Vamsi Kota, Shreya Desai, Guilherme Sacchi de Camargo Correia, Anand Patel, Adam Duvall, Neil Palmisiano, Emily Curran, Zulfa Omer, Rory M. Shallis, Anjali Advani, Mark Litzow
Publikováno v:
HemaSphere, Vol 7, p e9392932 (2023)
Externí odkaz:
https://doaj.org/article/7cabee1fb9eb446f93559e70c6817754
Autor:
Talha Badar, Ehab Atallah, Rory M. Shallis, Aaron D Goldberg, Ahmad Nanaa, Antoine Saliba, Anand Patel, Jan Bewersdorf, Adam Duvall, Madelyn Burkart, Danielle Bradshaw, Yasmin Abaza, Maximillian Stahl, Neil Palmisiano, Guru Subramanian Guru Murthy, Vamsi Kota, Amer M. Zeidan, Mark Litzow
Publikováno v:
HemaSphere, Vol 7, p e429374f (2023)
Externí odkaz:
https://doaj.org/article/b1a2758b33094e8786ec375831d5d7a3
Autor:
Jorge E. Cortes, Jeff H. Lipton, Vamsi Kota, Fausto Castagnetti, Sarit Assouline, Tim H. Brümmendorf, Eric Leip, Andrea Viqueira, Carlo Gambacorti-Passerini
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/0d1060e25573429d9aef0f679318bc15
Autor:
Nikhil S. Sahajpal, Ashis K. Mondal, Sudha Ananth, Allan Njau, Kimya Jones, Pankaj Ahluwalia, Eesha Oza, Ted M. Ross, Vamsi Kota, Arvind Kothandaraman, Sadanand Fulzele, Madhuri Hegde, Alka Chaubey, Amyn M. Rojiani, Ravindra Kolhe
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The COVID-19 pandemic has resulted in significant diversion of human and material resources to COVID-19 diagnostics, to the extent that influenza viruses and co-infection in COVID-19 patients remains undocumented and pose serious public-heal
Externí odkaz:
https://doaj.org/article/159ea4b76fc2461b8641e49ad87f0aca
Autor:
Pankaj Ahluwalia, Ashis K. Mondal, Meenakshi Ahluwalia, Nikhil S. Sahajpal, Kimya Jones, Yasmeen Jilani, Gagandeep K. Gahlay, Amanda Barrett, Vamsi Kota, Amyn M. Rojiani, Ravindra Kolhe
Publikováno v:
Cancer Medicine, Vol 11, Iss 6, Pp 1573-1586 (2022)
Abstract Understanding the complex tumor microenvironment is key to the development of personalized therapies for the treatment of cancer including colorectal cancer (CRC). In the past decade, significant advances in the field of immunotherapy have c
Externí odkaz:
https://doaj.org/article/ac4838910f06485e931a364e4f27103c
Autor:
Nikhil Shri Sahajpal, Ashis K. Mondal, Ashutosh Vashisht, Harmanpreet Singh, Andy Wing Chun Pang, Daniel Saul, Omar Nivin, Benjamin Hilton, Barbara R. DuPont, Vamsi Kota, Natasha M. Savage, Alex R. Hastie, Alka Chaubey, Ravindra Kolhe
Publikováno v:
Genes, Vol 14, Iss 9, p 1683 (2023)
Homologous recombination deficiency (HRD) is characterized by the inability of a cell to repair the double-stranded breaks using the homologous recombination repair (HRR) pathway. The deficiency of the HRR pathway results in defective DNA repair, lea
Externí odkaz:
https://doaj.org/article/bcc44605fe324681a2acb2264685e6b8